Posts Tagged ‘drug importation’

Tampa Pharmacist Speaks Out Against Florida’s Drug Importation Proposal

This editorial by Dan Fucarino was published in Florida Politics on April 1, 2019. Mr Fucarino is the owner and a pharmacist at Carrollwood Compounding Center & Pharmacy.

“The monetary rewards of Canadian prescriptions are just not worth their safety risks,” he warns. “I urge Florida legislators to listen to health care experts on this issue rather than the understandable populist appeals and vote no on this dangerous legislation — and then get back to working on more productive ways to lower drug prices for Floridians. Thousands of Americans have been injured or killed by imported prescription drugs.”


Drug Importation Claim vs. Fact At Florida Senate Subcommittee Hearing

Experts and leadership from The Partnership for Safe Medicines were in Tallahassee, Florida on Monday, March 25th for a Senate hearing on an ill-advised Canadian drug importation bill. During the hearing, our team heard many false or misleading statements about the proposal to take medicine out of the Canadian medicine supply and ship it to Florida. Here’s a fact check of the most egregious ones…


Florida House Bill 19 Would Expose Patients To Unregulated Prescription Drugs

Concerns over how much constituents pay for their medications have caused multiple states to introduce bills that would legalize drug importation. Florida’s House Bill 19 is just one example of legislators thinking that stepping outside the security of the U.S.’s drug supply chain is a smart option for their state…


PSM Went to Congress to Share Our Concerns About The Threat of Counterfeit Medicine

On Thursday, January 31, 2018, the Partnership for Safe Medicines held two briefings in Washington, D.C. to inform members of Congress and their staff about the dangers posed to Americans by counterfeit medicines. The events each had three panels and looked at how fake medicines have affected individuals and law enforcement, and also at the roles played by international bad actors and drug cartels…


Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year

The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.